FIELD: medicine.
SUBSTANCE: invention refers to medicine, particularly to phthisiology, and can be used in treating tuberculosis by antituberculous preparations (ATP). That is ensured by chemotherapy supplemented with daily introduction of the preparation taurin for at least 2 months.
EFFECT: method provides good tolerance to dosages of primary and reserve ATP required for therapy in various clinical forms of tuberculosis, reducing or eliminating various adverse reactions of therapy.
4 cl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR THE TREATMENT OF RESPIRATORY TUBERCULOSIS IN CHILDREN AND ADOLESCENTS IN THE EVENT OF ADVERSE REACTIONS | 2021 |
|
RU2772058C1 |
| Pleurotus 1137 PREPARATION FOR DRUG HYPERSENSITIVITY CORRECTION IN INTEGRATED THERAPY OF PULMONARY TUBERCULOSIS | 2010 |
|
RU2435600C1 |
| HERB MIXTURE OF TREATMENT OF PULMONARY TUBERCULOSIS | 2009 |
|
RU2411954C2 |
| METHOD FOR TREATMENT OF URINOGENITAL TUBERCULOSIS | 1995 |
|
RU2112568C1 |
| METHOD OF PREDICTION OF CLINICAL COURSE OF TUBERCULOSIS | 2015 |
|
RU2613320C2 |
| METHOD OF EVALUATING THE EFFECTIVENESS OF ANTI-TUBERCULOSIS THERAPY IN PATIENTS WITH GENITAL TUBERCULOSIS | 2014 |
|
RU2577723C2 |
| TUBERCULOSIS TREATMENT METHOD | 2002 |
|
RU2219939C1 |
| ANTITUBECULOUS-CAUSED MEDICAMENTOUS POLYNEUROPATHY APPROACH | 2007 |
|
RU2353360C2 |
| METHOD OF TREATING PATIENTS WITH DESTRUCTIVE FORMS OF PULMONARY TUBERCULOSIS | 2013 |
|
RU2521197C1 |
| METHOD OF TREATING PATIENTS SUFFERING PULMONARY TUBERCULOSIS | 2011 |
|
RU2456006C1 |
